What's Happening?
Amgen is currently seeking applicants for an undergraduate operations internship program in Cambridge, MA, for the summer of 2027. This approximately 13-week internship is designed to provide both project-based and experiential learning opportunities.
Interns will engage in initiatives, strategic analysis, and business case development across Amgen's five operations functions: Supply Chain, Process Development, Quality, Manufacturing, and Facilities & Engineering. The program also includes professional development through training sessions, one-on-one mentoring, and networking events. Applicants must be 18 years or older, currently enrolled in a full-time Bachelor’s Degree program with a minimum 3.0 GPA, and expected to complete one year of study before the internship begins. They must also be located in the United States for the duration of the program and available to work full-time.
Why It's Important?
This internship program is significant for several reasons. For students, it offers a valuable opportunity to gain practical experience in the biotechnology industry, specifically within a global biopharmaceutical company like Amgen. This hands-on experience can be crucial for career development, providing insights into real-world operations and potentially leading to future employment opportunities. For Amgen, the program serves as a pipeline for identifying and nurturing future talent, bringing fresh perspectives and skills into the organization. It also reinforces Amgen's commitment to fostering scientific and operational excellence. The focus on operations functions is particularly important as it underpins the efficient development, manufacturing, and delivery of medicines to patients, directly impacting public health and the company's ability to serve its mission.
What's Next?
Amgen will continue to accept applications until a sufficient number are received or a candidate is selected. Successful interns will have the opportunity to make effective recommendations to senior leadership and network with colleagues across the company. While sponsorship for future full-time roles is not guaranteed, the program aims to prepare interns for potential future employment by July 2028. The experience gained will be highly beneficial for the interns' resumes and future career prospects in the biotechnology and pharmaceutical sectors. Amgen will likely continue to offer similar internship programs in subsequent years, reflecting an ongoing commitment to talent development and industry innovation.
Beyond the Headlines
Beyond the immediate benefits to interns and Amgen, this program highlights the broader trend of companies investing in early-career talent development. Such internships are vital for bridging the gap between academic learning and professional practice, ensuring that the next generation of the workforce is well-equipped to meet industry demands. For the biotechnology sector, these programs are critical for maintaining a skilled workforce, especially in specialized areas like operations, which are essential for bringing life-saving medicines to market. The emphasis on professional development, mentoring, and networking also underscores a holistic approach to talent cultivation, recognizing that technical skills alone are not sufficient for long-term career success. This initiative contributes to the overall strength and innovation capacity of the U.S. biopharmaceutical industry.
